company background image
FNAM logo

Evolutionary Genomics OTCPK:FNAM Stock Report

Last Price

US$0.0008

Market Cap

US$5.3k

7D

0%

1Y

n/a

Updated

12 Oct, 2024

Data

Company Financials

Evolutionary Genomics, Inc.

OTCPK:FNAM Stock Report

Market Cap: US$5.3k

FNAM Stock Overview

Engages in the research and identification of positively selected genes in humans, animals, and commercial crops. More details

FNAM fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

Evolutionary Genomics, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Evolutionary Genomics
Historical stock prices
Current Share PriceUS$0.0008
52 Week HighUS$0.0008
52 Week LowUS$0.0008
Beta0
11 Month Change0%
3 Month Changen/a
1 Year Changen/a
33 Year Change-99.91%
5 Year Change-99.95%
Change since IPO-99.97%

Recent News & Updates

Recent updates

Shareholder Returns

FNAMUS BiotechsUS Market
7D0%2.4%0.5%
1Yn/a15.6%30.7%

Return vs Industry: Insufficient data to determine how FNAM performed against the US Biotechs industry.

Return vs Market: Insufficient data to determine how FNAM performed against the US Market.

Price Volatility

Is FNAM's price volatile compared to industry and market?
FNAM volatility
FNAM Average Weekly Movementn/a
Biotechs Industry Average Movement9.9%
Market Average Movement6.3%
10% most volatile stocks in US Market16.3%
10% least volatile stocks in US Market3.1%

Stable Share Price: FNAM's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine FNAM's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/a3Steve Warneckewww.evolgen.com

Evolutionary Genomics, Inc., together with its subsidiaries, engages in the research and identification of positively selected genes in humans, animals, and commercial crops. The company develops Adapted Traits Platform, a technology platform to identify genes for enhancing crop plant traits, such as yield, sugar content, biomass, drought tolerance, and pest/disease resistance. It serves governmental organizations, non-profit foundations, and commercial entities.

Evolutionary Genomics, Inc. Fundamentals Summary

How do Evolutionary Genomics's earnings and revenue compare to its market cap?
FNAM fundamental statistics
Market capUS$5.32k
Earnings (TTM)-US$2.25m
Revenue (TTM)n/a

0.0x

P/S Ratio

0.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
FNAM income statement (TTM)
RevenueUS$0
Cost of RevenueUS$0
Gross ProfitUS$0
Other ExpensesUS$2.25m
Earnings-US$2.25m

Last Reported Earnings

Dec 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)0
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0.0%

How did FNAM perform over the long term?

See historical performance and comparison